Showing results (361-370 of 491) with videos related to
Sort By:
Pageof 50
Gynecologic Oncology|June 16, 2019
Secondary surgical resection for patients with recurrent uterine leiomyosarcomaPaulina Cybulska, Vasileios Sioulas, Theofano Orfanelli, et al.Gynecologic Oncology|November 24, 2022
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trialLea A Moukarzel, Nguyen Nguyen, Qin Zhou, et al.Journal of the National Cancer Institute|June 14, 2022
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial CarcinomaNida S Safdar, Marina Stasenko, Pier Selenica, et al.Gynecologic Oncology|September 5, 2022
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenterationEric Rios-Doria, Olga T Filippova, Alli M Straubhar, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 10, 2025
Preoperative immunonutrition for patients who undergo primary cytoreductive surgery for ovarian cancerRyan Kahn, Evan Smith, Kimberly Murphy, et al.Gynecologic Oncology Reports|February 15, 2024
Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulationsTiffany Y Sia, Zvi Yaari, Ron Feiner, et al.Gynecologic Oncology|January 19, 2016
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer centerJennifer J Mueller, Qin C Zhou, Alexia Iasonos, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.JCO Precision Oncology|September 11, 2020
Endometrial Cancers in <i>BRCA1</i> or <i>BRCA2</i> Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair DefectsEvan S Smith, Arnaud Da Cruz Paula, Karen A Cadoo, et al.Pageof 50